[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back

Go back to trials list

Cerebrovascular Dysregulation in Chronic Kidney Disease


Description

The purpose of this study is to test whether or not regular exercise training may improve brain blood flow regulation in patients with chronic kidney disease (CKD).Prior research has shown that CKD patients have an increased risk of stroke and that impairments in brain blood flow regulation predict stroke in other chronic disease states. This study will test whether exercise training can improve brain blood flow regulation via improved dynamic cerebral autoregulation and cerebrovascular carbon dioxide reactivity in CKD. Participants will undergo exercise training on a stationary bicycle, or stretching exercises, 3 times per week for 12 weeks.

Trial Eligibility

Inclusion Criteria: • Individuals with chronic kidney disease stages III-IV. Exclusion Criteria: * Heart failure * Chronic obstructive pulmonary disease * Uncontrolled hypertension or hypotension * Pregnancy or plans to become pregnant * Inability to exercise on a stationary bicycle * Current participation in exercise more than 20 minutes twice per week

Study Info

Organization

University of North Texas, Denton, TX


Primary Outcome

change in dynamic cerebral autoregulation


Outcome Timeframe Mean arterial pressure-middle cerebral artery blood velocity transfer function phase (radians) and gain (cm/s/mmHg) will be compared at baseline (week 0) and after completing the 12-week intervention (week 13).

NCTID NCT05571605

Phases NA

Primary Purpose TREATMENT

Start Date 2022-08-01

Completion Date 2025-03

Enrollment Target 40

Interventions

BEHAVIORAL Exercise

BEHAVIORAL Stretching

Locations Recruiting

University of North Texas

United States, Texas, Denton


Interested in joining this trial?

Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.

newsletter icon

Get the latest thought leadership on your Large Granular Lymphocytic Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.